LAYNE LEMAIRE: Open Payments
NPI 1235554791 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,055 in 143 payments from 30 companies in 2025. Trend: 2023 $2,262 · 2024 $2,869 · 2025 $3,055
Food & beverage: $2,950Education: $105
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 30 | $468 |
| ABBVIE INC. | 14 | $374 |
| Janssen Biotech, Inc. | 9 | $357 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $188 |
| UCB, Inc. | 9 | $178 |
| Insulet Corporation | 7 | $160 |
| Radius Health, Inc. | 6 | $150 |
| GENZYME CORPORATION | 6 | $145 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
Products named: TREMFYA, SKYRIZI, OTEZLA, Bimzelx, TAVNEOS, Omnipod, Tymlos, KEVZARA.
Industry payments across LA — which companies pay providers there.
